Candel Therapeutics, Inc.
CADL
$12.17
-$0.43-3.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 201.57M | 194.83M | 119.73M | 86.96M | 100.69M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.59M | 2.92M | 1.66M | 3.17M | 2.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 204.16M | 197.75M | 121.39M | 90.13M | 103.61M |
|
|
|||||
| Total Current Assets | 204.16M | 197.75M | 121.39M | 90.13M | 103.61M |
| Net Property, Plant & Equipment | 3.48M | 3.64M | 3.30M | 3.11M | 2.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 514.00K | 524.00K | 503.00K | 351.00K | 311.00K |
| Total Assets | 208.15M | 201.92M | 125.20M | 93.60M | 105.97M |
|
|
|||||
| Total Accounts Payable | 5.15M | 3.04M | 1.13M | 1.12M | 1.95M |
| Total Accrued Expenses | 6.52M | 2.98M | 6.87M | 5.09M | 4.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 461.00K | 453.00K | 445.00K | 4.66M | 7.30M |
| Total Finance Division Other Current Liabilities | 555.00K | 579.00K | 553.00K | 55.00K | 1.41M |
| Total Other Current Liabilities | 555.00K | 579.00K | 553.00K | 55.00K | 1.41M |
| Total Current Liabilities | 12.69M | 7.05M | 9.00M | 10.93M | 14.72M |
|
|
|||||
| Total Current Liabilities | 12.69M | 7.05M | 9.00M | 10.93M | 14.72M |
| Long-Term Debt | 47.83M | 47.48M | 47.13M | 973.00K | 939.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.23M | 1.34M | 1.46M | 1.57M | 104.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.28M | 8.02M | 15.69M | -- | -- |
| Total Liabilities | 82.02M | 63.89M | 73.27M | 13.47M | 15.76M |
|
|
|||||
| Common Stock & APIC | 404.73M | 377.73M | 282.76M | 281.46M | 280.28M |
| Retained Earnings | -278.15M | -239.25M | -230.39M | -200.89M | -189.62M |
| Treasury Stock & Other | -448.00K | -448.00K | -448.00K | -448.00K | -448.00K |
| Total Common Equity | 126.13M | 138.03M | 51.92M | 80.12M | 90.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 126.13M | 138.03M | 51.92M | 80.12M | 90.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.13M | 138.03M | 51.92M | 80.12M | 90.21M |
|
|
|||||